SpaMedica

SpaMedica is a leading specialist provider of NHS eye healthcare services, focusing on cataract surgery in the UK. With a strong commitment to offering top-notch eye care in safe and comfortable environments, the company also provides services such as YAG Capsulotomy for PCO, Vitrectomy Surgery, and Age-related Macular Degeneration treatments. Notably, in 2018, SpaMedica emerged as the largest provider of NHS cataract surgery in the UK, conducting over 20,000 surgeries annually. The company's 54 hospitals, equipped with state-of-the-art technology, are spread across England and have consistently received impressive ratings from the Care Quality Commission. Additionally, SpaMedica has garnered over 15,000 5-star ratings from patients, solidifying its position as a top-rated healthcare provider. Recognized for its exceptional performance and staff focus, SpaMedica achieved gold status from Investors in People, placing it in the top 3% globally. The company's growth trajectory is noteworthy, and its dedication to maintaining high standards of care and patient outcomes positions it as an attractive investment opportunity.

SpaMedica's latest investment, a Private Equity Round investment, was secured on 13 September 2016 with CBPE Capital as the investing firm. The company's unique value proposition, impressive track record, and commitment to revolutionizing eye healthcare in the UK make it a compelling prospect for venture capitalists seeking opportunities in the Health Care industry.